Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Nociceptin receptor | ||
Ligand | BDBM50100982 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_1452449 (CHEMBL3362473) | ||
Ki | 20±n/a nM | ||
Citation | Schunk, S; Linz, K; Frormann, S; Hinze, C; Oberbörsch, S; Sundermann, B; Zemolka, S; Englberger, W; Germann, T; Christoph, T; Kögel, BY; Schröder, W; Harlfinger, S; Saunders, D; Kless, A; Schick, H; Sonnenschein, H Discovery of Spiro[cyclohexane-dihydropyrano[3,4-b]indole]-amines as Potent NOP and Opioid Receptor Agonists. ACS Med Chem Lett5:851-6 (2014) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Nociceptin receptor | |||
Name: | Nociceptin receptor | ||
Synonyms: | KOR-3 | Kappa-type 3 opioid receptor | Mu-type opioid receptor (Mu) | NOP | Nociceptin Receptor (ORL1 Receptor) | Nociceptin receptor (NOP) | Nociceptin receptor (ORL-1) | Nociceptin receptor (ORL1) | Nociceptin/Orphanin FQ, NOP receptor | OOR | OPIATE ORL-1 | OPRL1 | OPRL1 protein | OPRX_HUMAN | ORL1 | ORL1 receptor | Opioid receptor like-1 | Orphanin FQ receptor | Orphanin FQ receptor (ORL1) | P41146 | ||
Type: | G Protein-Coupled Receptor (GPCR) | ||
Mol. Mass.: | 40702.87 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P41146 | ||
Residue: | 370 | ||
Sequence: |
| ||
BDBM50100982 | |||
n/a | |||
Name | BDBM50100982 | ||
Synonyms: | CHEMBL3326225 | ||
Type | Small organic molecule | ||
Emp. Form. | C24H30N2O | ||
Mol. Mass. | 362.5078 | ||
SMILES | CN(C)[C@]1(CC[C@@H](CC1)OCCc1c[nH]c2ccccc12)c1ccccc1 |r,wU:3.2,wD:6.9,(31.51,-13.84,;30.17,-13.07,;30.17,-11.53,;28.84,-13.84,;28.07,-15.17,;26.53,-15.18,;25.76,-13.85,;26.53,-12.52,;28.07,-12.51,;24.22,-13.85,;23.42,-15.17,;21.88,-15.14,;21.08,-16.46,;21.68,-17.88,;20.51,-18.89,;19.2,-18.09,;17.73,-18.54,;16.61,-17.49,;16.95,-15.98,;18.43,-15.54,;19.55,-16.59,;29.64,-15.16,;28.89,-16.51,;29.69,-17.83,;31.23,-17.8,;31.97,-16.44,;31.17,-15.12,)| | ||
Structure |